CN114098070A - Wolfberry raw juice compound eye-protecting oral liquid and preparation method thereof - Google Patents
Wolfberry raw juice compound eye-protecting oral liquid and preparation method thereof Download PDFInfo
- Publication number
- CN114098070A CN114098070A CN202111519541.1A CN202111519541A CN114098070A CN 114098070 A CN114098070 A CN 114098070A CN 202111519541 A CN202111519541 A CN 202111519541A CN 114098070 A CN114098070 A CN 114098070A
- Authority
- CN
- China
- Prior art keywords
- juice
- parts
- oral liquid
- medlar
- raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000011389 fruit/vegetable juice Nutrition 0.000 title claims abstract description 71
- 150000001875 compounds Chemical class 0.000 title claims abstract description 38
- 239000007788 liquid Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 235000015468 Lycium chinense Nutrition 0.000 title claims description 19
- 235000015459 Lycium barbarum Nutrition 0.000 title claims description 17
- 244000241838 Lycium barbarum Species 0.000 title claims 7
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 35
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 35
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 35
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 25
- 235000008104 Prunus humilis Nutrition 0.000 claims abstract description 23
- 241000057271 Prunus humilis Species 0.000 claims abstract description 23
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 22
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims abstract description 18
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims abstract description 18
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims abstract description 18
- 235000010930 zeaxanthin Nutrition 0.000 claims abstract description 18
- 239000001775 zeaxanthin Substances 0.000 claims abstract description 18
- 229940043269 zeaxanthin Drugs 0.000 claims abstract description 18
- -1 zeaxanthin ester Chemical class 0.000 claims abstract description 18
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 17
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 17
- 239000011648 beta-carotene Substances 0.000 claims abstract description 17
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 17
- 229960002747 betacarotene Drugs 0.000 claims abstract description 17
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 13
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 12
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000011259 mixed solution Substances 0.000 claims abstract description 12
- 239000000811 xylitol Substances 0.000 claims abstract description 12
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 12
- 235000010447 xylitol Nutrition 0.000 claims abstract description 12
- 229960002675 xylitol Drugs 0.000 claims abstract description 12
- 238000011049 filling Methods 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims abstract description 6
- 239000010935 stainless steel Substances 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 244000182216 Mimusops elengi Species 0.000 claims description 32
- 235000005706 Prunus prostrata Nutrition 0.000 claims description 13
- 241000723353 Chrysanthemum Species 0.000 claims description 12
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000009928 pasteurization Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 239000000084 colloidal system Substances 0.000 claims description 4
- 238000003801 milling Methods 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 238000004537 pulping Methods 0.000 claims description 2
- 238000007670 refining Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 210000001508 eye Anatomy 0.000 abstract description 9
- 229960005375 lutein Drugs 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 7
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract description 7
- 208000003464 asthenopia Diseases 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 3
- 235000013361 beverage Nutrition 0.000 abstract description 2
- 241000628997 Flos Species 0.000 abstract 3
- 240000002624 Mespilus germanica Species 0.000 abstract 3
- 235000008210 xanthophylls Nutrition 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 235000012680 lutein Nutrition 0.000 description 6
- 239000001656 lutein Substances 0.000 description 6
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 6
- 239000000049 pigment Substances 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 4
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 2
- 206010013774 Dry eye Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 102000004330 Rhodopsin Human genes 0.000 description 2
- 108090000820 Rhodopsin Proteins 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 229940107604 lutein esters Drugs 0.000 description 2
- 150000002658 luteins Chemical class 0.000 description 2
- 208000002780 macular degeneration Diseases 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 241000609240 Ambelania acida Species 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- QAGGICSUEVNSGH-UHFFFAOYSA-N Diosmetin Natural products C1=C(O)C(OC)=CC=C1C1=CC(=O)C2=CC=C(O)C=C2O1 QAGGICSUEVNSGH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960001876 diosmetin Drugs 0.000 description 1
- 235000015428 diosmetin Nutrition 0.000 description 1
- MBNGWHIJMBWFHU-UHFFFAOYSA-N diosmetin Chemical compound C1=C(O)C(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 MBNGWHIJMBWFHU-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004384 eye physiology Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000000909 keratomalacia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medlar normal juice compound eye-protecting oral liquid and a preparation method thereof. The invention discloses a medlar normal juice compound eye-protecting oral liquid which comprises the following raw materials: fructus Lycii natural juice, Prunus humilis original juice, xylitol, flos Chrysanthemi extract, beta-carotene, lutein ester, and zeaxanthin ester. The preparation method of the medlar normal juice compound eye-protecting oral liquid comprises the following steps: taking fructus Lycii natural juice, Prunus humilis Bunge natural juice, xylitol, flos Chrysanthemi extract, beta-carotene, lutein ester, and zeaxanthin ester, placing in stainless steel emulsifying tank, stirring to obtain fructus Lycii natural juice compound mixed solution, filling the fructus Lycii natural juice compound mixed solution into oral liquid bottle, and pasteurizing to obtain fructus Lycii natural juice compound eye-protecting oral liquid. The oral liquid is prepared from fructus Lycii juice and Prunus humilis juice as main materials, and flos Chrysanthemi extract, xanthophyll ester, zeaxanthin ester, beta-carotene, etc. as nutritional health promotion factors. The beverage is rich in nutrition and has good effects of relieving asthenopia and protecting eyes.
Description
Technical Field
The invention relates to an oral liquid, and particularly relates to a medlar original juice compound eye-protecting oral liquid and a preparation method thereof.
Background
Asthenopia is currently the most common chronic disease in ophthalmology. The main symptoms are blurred vision, dry eyes, sour and swollen feeling or pain around eyeballs and eye sockets, and the like. With the popularization of smart phones and the high-speed development of short video industries, screen information is ubiquitous, and a video family appears in China. According to the statistical report of the development conditions of the internet in China, as long as 12 months in 2020, the scale of the netizens in China reaches 9.89 hundred million, the scale of the netizens in mobile phones reaches 9.86 hundred million, and the average internet surfing time of each netizen per week is 26.2 hours, which is equivalent to 3.7 hours per day. Of the 9.44 million network video users, each netizen watches internet video programs (including short videos) for about 100 minutes each day on average. The time of using the eyesight is prolonged continuously, the eye burden is getting more and more serious, and the eye health is threatened greatly. Therefore, it is necessary to develop a food for effectively relieving asthenopia and improving eyesight.
At present, the medlar concentrated juice is matched with other herbal plant extract with the eye protection effect in a common way, for example, a black and red medlar compound eye protection oral liquid and a preparation method thereof with the patent publication number of CN 108208835A. However, the main materials in the formula of the patent lose functional components, nutrient components and trace elements of the pigment through extraction and concentration, and the functional characteristics are reduced. The adoption of the raw juice of medlar and the raw juice of cerasus humilis not only keeps all natural nutrient components but also balances the efficacy of the product. In addition, the absorptivity and efficacy of the product are enhanced by adding beta-carotene, lutein ester and zeaxanthin ester, so that a formula which is comprehensive in nutrition and has the effects of relieving asthenopia and improving vision is developed.
The medlar is a traditional rare Chinese medicinal material and an important economic crop in China. The medlar contains abundant medlar polysaccharide, beta-carotene, vitamin E, selenium, flavonoid and other substances, has the effects of nourishing yin, tonifying kidney and improving eyesight, and is often eaten by people as a health food. Recent medical research finds that the medlar has certain auxiliary treatment effect on the retina diseases of ophthalmology, and mainly has the effects of relieving macular degeneration of retina, relieving xerophthalmia and supplementing pigments.
Cerasus humilis is called "calcium fruit" because the fruit is rich in active calcium and easy to be absorbed. Calcium is a "messenger" in the nerve and is involved in the various nerve impulses. Calcium is an important element for protecting eye tissues and has important functions of maintaining normal physiology of eye muscles and firmness and elasticity of sclera. The lack of calcium can cause the retinal elasticity to decline, the anterior-posterior diameter of the eyeball to elongate, meanwhile, the corneal ciliary muscle is degenerated pathologically, and the elasticity of the eyeball wall muscle declines to develop myopia. Therefore, the cerasus humilis has the effects of supplementing calcium and preventing myopia. In addition, the cerasus humilis is rich in flavonoids, amino acids, natural pigments, vitamins and various mineral trace elements, and has high nutritive value.
The chrysanthemum contains rich flavonoid compounds, and researches show that the flavonoid monomers of apigenin, luteolin, baicalein, quercetin and diosmetin in the chrysanthemum have a protective effect on eyes.
Xylitol is a natural plant sweetener extracted from birch, oak, corn cob, bagasse, etc. Has effects in loosening bowel, relieving constipation, improving liver health, and preventing dental caries.
Beta-carotene: the natural pigment is a vitamin A precursor, and a proper amount of beta-carotene can promote rhodopsin to reach the normal content, so that the slow adaptation of dark fields caused by the lack of vitamin A is avoided, and the damage of bright light to eyes after the dark fields is also avoided. In addition, night blindness, dry eye, corneal ulceration and keratomalacia can be prevented. It is recommended to take 15-50 mg daily.
Lutein ester is ester formed by lutein and various unsaturated fatty acids, and the lutein ester is decomposed into lutein under the action of enzyme after being taken into a human body. Lutein, also known as "eyegold", is one of natural carotenoids and has the effects of promoting regeneration of rhodopsin in retinal cells, improving visual acuity, preventing age-related (fundus) macular degeneration and the like. Many ophthalmic diseases are greatly related to the deficiency of lutein, but lutein and lutein esters cannot be synthesized in human bodies, so that proper supplement of lutein and lutein esters can effectively protect retina and prevent cataract. Lutein ester approved by the national ministry of health is a new resource functional food, can be widely used in the fields of food and medicine, and is regulated to be less than 12mg per day.
Zeaxanthin ester is an important carotenoid fatty acid ester, and is decomposed into zeaxanthin under the action of enzyme after being taken into human body. Zeaxanthin is a natural pigment, and is the most important nutrient component in retina and the main essential component for forming macula lutea area of retina. The yellow pigment can be increased by increasing zeaxanthin intake in short term, enhancing the ability of macula to resist harmful substances and light ray damage, and preventing and relieving senile macular degeneration, with maximum usage amount of 5.0 g/kg.
Disclosure of Invention
The invention aims to provide the medlar normal juice compound eye-protecting oral liquid which has comprehensive nutrition and has the functions of relieving visual fatigue and improving eyesight.
The medlar normal juice compound eye-protecting oral liquid is characterized by comprising the following raw materials in parts by weight: 50-85 parts of raw wolfberry juice, 20-60 parts of raw prunus humilis juice, 4-10 parts of xylitol, 1-5 parts of chrysanthemum extract, 0.1-1 part of beta-carotene, 0.01-0.1 part of lutein ester and 0.01-0.2 part of zeaxanthin ester.
Further, the composition comprises the following components in parts by weight: 75 parts of medlar normal juice, 35 parts of prunus humilis normal juice, 8 parts of xylitol, 3 parts of chrysanthemum extract, 0.5 part of beta-carotene, 0.05 part of lutein ester and 0.05 part of zeaxanthin ester.
The raw juice of Chinese wolfberry is prepared from fresh Chinese wolfberry fruit through washing, crushing, pulping, colloid milling, homogenizing, sterilizing and filling. The cerasus humilis raw juice is prepared by taking fresh cerasus humilis fruits as raw materials and carrying out the working procedures of raw material selection, cleaning, cold squeezing, colloid milling, homogenization, sterilization, filling and the like.
The preparation method of the medlar normal juice compound eye-protecting oral liquid is characterized by comprising the following steps:
1) taking 50-85 parts of raw wolfberry juice, 20-60 parts of raw cerasus humilis juice, 4-10 parts of xylitol, 1-5 parts of chrysanthemum extract, 0.1-1 part of beta-carotene, 0.02-0.1 part of lutein ester and 0.005-0.2 part of zeaxanthin ester in a stainless steel emulsifying tank, stirring for 10-15 minutes at 20-30 r/min to prepare a raw wolfberry juice compound mixed solution,
2) and filling the compound mixed solution of the raw wolfberry juice into 30ml of oral liquid bottles, performing pasteurization, and performing sterilization for 25-45min under the water bath condition at the temperature of 80-90 ℃ to obtain the compound eye-protecting oral liquid of the raw wolfberry juice.
The pasteurization in step 2) is carried out in water bath at 80-90 deg.C for 25-45 min.
The invention relates to a medlar original juice compound eye-protecting oral liquid and a preparation method thereof, wherein the oral liquid mainly comprises medlar original juice and cerasus humilis original juice, and chrysanthemum extract, lutein ester, zeaxanthin ester, beta-carotene and other nutrition and health care factors are added. The beverage is rich in nutrition and has good effects of relieving asthenopia and protecting eyes. Compared with the prior art, the invention at least has the following advantages: 1) the medlar original juice and the cerasus humilis original juice are adopted, so that all natural nutritional ingredients of the medlar original juice and the cerasus humilis original juice are reserved, and the efficacy of the product is balanced; 2) the oral liquid has good taste and color and is easy to popularize in the market; 3) the invention has the advantages of simple process, low cost and easy realization of industrial production.
Detailed Description
The invention aims to provide a medlar normal juice compound eye-protecting oral liquid.
The present invention is described in further detail below with reference to specific embodiments, which are given for the purpose of illustration only and are not intended to limit the scope of the invention.
Example 1:
1) taking 75 parts of raw wolfberry juice, 35 parts of prunus humilis juice, 8 parts of xylitol, 3 parts of chrysanthemum extract, 0.5 part of beta-carotene, 0.05 part of lutein ester and 0.05 part of zeaxanthin ester in a stainless steel emulsifying tank, and stirring for 12 minutes at 30 r/min to prepare a raw wolfberry juice compound mixed solution;
2) and filling the compound medlar normal juice compound mixed solution into a 30ml oral liquid bottle, performing pasteurization, and sterilizing for 30min under the condition of water bath at the temperature of 85 ℃ to obtain the compound medlar normal juice eye-protecting oral liquid.
Example 2:
1) taking 50 parts of medlar normal juice, 60 parts of prunus humilis normal juice, 10 parts of xylitol, 1 part of chrysanthemum extract, 1 part of beta-carotene, 0.1 part of lutein ester and 0.2 part of zeaxanthin ester in a stainless steel emulsifying tank, and stirring for 15 minutes at 20 r/min to prepare medlar normal juice compound mixed solution;
2) and filling the compound medlar normal juice compound mixed solution into a 30ml oral liquid bottle, performing pasteurization, and performing sterilization for 25min under the water bath condition at the temperature of 80 ℃ to obtain the compound medlar normal juice eye-protecting oral liquid.
Example 3:
1) taking 85 parts of raw wolfberry juice, 20 parts of raw prunus humilis juice, 4 parts of xylitol, 1 part of chrysanthemum extract, 0.1 part of beta-carotene, 0.02 part of lutein ester and 0.005 part of zeaxanthin ester in a stainless steel emulsifying tank, and stirring for 15 minutes at 30 r/min to prepare a raw wolfberry juice compound mixed solution;
2) and filling the compound medlar normal juice compound mixed solution into a 30ml oral liquid bottle, performing pasteurization, and performing sterilization for 45min under the water bath condition at the temperature of 90 ℃ to obtain the compound medlar normal juice eye-protecting oral liquid.
Claims (5)
1. The medlar normal juice compound eye-protecting oral liquid is characterized by comprising the following raw materials in parts by weight: 50-85 parts of raw wolfberry juice, 20-60 parts of raw prunus humilis juice, 4-10 parts of xylitol, 1-5 parts of chrysanthemum extract, 0.1-1 part of beta-carotene, 0.01-0.1 part of lutein ester and 0.01-0.2 part of zeaxanthin ester.
2. The medlar normal juice compound eye-protecting oral liquid according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 75 parts of medlar normal juice, 35 parts of prunus humilis normal juice, 8 parts of xylitol, 3 parts of chrysanthemum extract, 0.5 part of beta-carotene, 0.05 part of lutein ester and 0.05 part of zeaxanthin ester.
3. The compound medlar normal juice eye-protecting oral liquid according to claim 1 or 2, wherein the medlar normal juice is prepared by using fresh medlar as raw material and through the processes of cleaning, crushing, pulping, colloid milling, homogenizing, sterilizing, filling and the like,
the cerasus humilis raw juice is prepared by taking fresh cerasus humilis fruits as raw materials and refining the raw materials through the working procedures of raw material selection, cleaning, cold squeezing, colloid milling, homogenization, sterilization, filling and the like.
4. The preparation method of the wolfberry raw juice compound eye-protecting oral liquid according to claim 1 or 2, which is characterized by comprising the following steps:
1) taking 50-85 parts of raw wolfberry juice, 20-60 parts of raw cerasus humilis juice, 4-10 parts of xylitol, 1-5 parts of chrysanthemum extract, 0.1-1 part of beta-carotene, 0.02-0.1 part of lutein ester and 0.005-0.2 part of zeaxanthin ester in a stainless steel emulsifying tank, stirring for 10-15 minutes at 20-30 r/min to prepare a raw wolfberry juice compound mixed solution,
2) and filling the compound mixed solution of the raw wolfberry juice into an oral liquid bottle, and performing pasteurization to obtain the compound eye-protecting oral liquid of the raw wolfberry juice.
5. The method for preparing the medlar normal juice compound eye-protecting oral liquid according to claim 4, wherein the pasteurization in the step (2) is carried out for 25-45min under the water bath condition with the temperature of 80-90 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111519541.1A CN114098070A (en) | 2021-12-14 | 2021-12-14 | Wolfberry raw juice compound eye-protecting oral liquid and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111519541.1A CN114098070A (en) | 2021-12-14 | 2021-12-14 | Wolfberry raw juice compound eye-protecting oral liquid and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114098070A true CN114098070A (en) | 2022-03-01 |
Family
ID=80364785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111519541.1A Pending CN114098070A (en) | 2021-12-14 | 2021-12-14 | Wolfberry raw juice compound eye-protecting oral liquid and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114098070A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009019712A1 (en) * | 2007-08-03 | 2009-02-12 | Omniactive Health Technologies Pvt Ltd. | Novel xanthophyll composition contaning (trans, meso) - zeaxanthin, and a process for its preparation |
CN101647493A (en) * | 2008-08-14 | 2010-02-17 | 白心亮 | Lutein Chinese wolfberry blueberry eye protecting milk tablet |
CN104256827A (en) * | 2014-10-17 | 2015-01-07 | 山东禹王制药有限公司 | Vision-improving oral liquid and preparation method thereof |
US20160151437A1 (en) * | 2014-06-02 | 2016-06-02 | Viva Pharmaceutical, Inc. | Nutritional supplements for improved vision and methods of treating the same |
CN109805400A (en) * | 2017-11-20 | 2019-05-28 | 威海紫光科技园有限公司 | A kind of cowberry lutein health food for alleviating visual fatigue |
CN110771836A (en) * | 2019-11-25 | 2020-02-11 | 宁夏宝丰生态牧场有限公司 | Wolfberry and calcium fruit jam and preparation method thereof |
-
2021
- 2021-12-14 CN CN202111519541.1A patent/CN114098070A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009019712A1 (en) * | 2007-08-03 | 2009-02-12 | Omniactive Health Technologies Pvt Ltd. | Novel xanthophyll composition contaning (trans, meso) - zeaxanthin, and a process for its preparation |
CN101647493A (en) * | 2008-08-14 | 2010-02-17 | 白心亮 | Lutein Chinese wolfberry blueberry eye protecting milk tablet |
US20160151437A1 (en) * | 2014-06-02 | 2016-06-02 | Viva Pharmaceutical, Inc. | Nutritional supplements for improved vision and methods of treating the same |
CN104256827A (en) * | 2014-10-17 | 2015-01-07 | 山东禹王制药有限公司 | Vision-improving oral liquid and preparation method thereof |
CN109805400A (en) * | 2017-11-20 | 2019-05-28 | 威海紫光科技园有限公司 | A kind of cowberry lutein health food for alleviating visual fatigue |
CN110771836A (en) * | 2019-11-25 | 2020-02-11 | 宁夏宝丰生态牧场有限公司 | Wolfberry and calcium fruit jam and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048201B (en) | Novel fruit and vegetable beverage | |
CN104287013B (en) | A kind of reducing blood lipid function of blood sugar reduction sexual health vinegar beverage and production technology thereof | |
CN102742656B (en) | Milky tea relieving asthenopia and preparation method thereof | |
KR20090084492A (en) | Mixed tea composition having the improved taste, and preparation thereof | |
US20090297618A1 (en) | Composition beneficial for visuognosis persistence and use thereof | |
CN102763847A (en) | Health-care food with function of relieving visual fatigue and preparation method thereof | |
CN107279646A (en) | Anti- eye fatigue chrysanthemum cream and preparation method thereof | |
Yampolsky et al. | Apricot (lat. Prunus armeniaca Lin.) | |
CN112602861A (en) | Basidiomycetes composite beverage for improving immunity and preparation method thereof | |
CN1824063B (en) | Medicine and food dual purpose Chinese and western medicine combined product for preventing and trecting pseudomyopia | |
CN113826894A (en) | Capsule for relieving visual fatigue and preparation method thereof | |
CN105412354A (en) | Eye protecting lollipop containing lycium ruthenicum Murr. | |
CN1824025B (en) | Applicaiton of a Chinese-western medicine combined composition for preparing medicine and frod dual purpose nutrient for preventing frue myopia | |
CN1824053A (en) | Medicine and food dual purpose product for preventing pseudomyopia and true myopia and its manufacturing method | |
CN1824067A (en) | Medicine and food dual purpose product for preventing myopia and its manufacturing method | |
CN104222284A (en) | Anti-radiation health-care milk for alleviating asthenopia and preparation method thereof | |
CN104337927A (en) | Calyx seu fructus physalis extractive, medicine composition and/or functional food | |
CN1824066A (en) | Medicine and food dual purpose Chinese and western medicine combined product for preventing myopia and its manufacturing method | |
CN1824064A (en) | Medicine and food dual purpose nutrient for preventing and treating pseudomyopia and its manufacturing method | |
CN114098070A (en) | Wolfberry raw juice compound eye-protecting oral liquid and preparation method thereof | |
CN102948853A (en) | Yangtao beverage rich in natural SOD (Superoxide Dismutase) | |
CN104705725A (en) | Physalis pubescens beverage beneficial for eyesight protection and preparation method thereof | |
CN109432191A (en) | A kind of eye sticker and preparation method thereof for alleviating asthenopia | |
CN104172376A (en) | Aloe and blueberry fruit granule beverage and preparation technology thereof | |
CN108354143A (en) | Composition for relieving asthenopia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220301 |
|
WD01 | Invention patent application deemed withdrawn after publication |